Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804
·
clinicaltrials.gov ↗
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Lymphoid Neoplasm
Interventions
OTHER:
non-interventional
Sponsor
Chinese Academy of Medical Sciences